Licensing UCLA technology to startup companies enables UCLA to be a strong economic engine for the Los Angeles region, California and beyond. Below is a partial listing of such startups that have agreed to be showcased on our website.
Acteris, Inc. is a privately held development stage biotechnology company engaged in improving development and use of novel cancer immunotherapeutic products. It focuses on targeting cancer immunotherapies to specific tumors, patients, and therapeutic combinations to optimize patient outcomes.
Aneeve Nanotechnologies is a startup company spun-out of UCLA and USC developing nano enabled electronics to bridge the gap between emerging and traditional platforms for communication and digital applications.
Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company focused on developing breakthrough medicines for the treatment of hormonally-driven cancers.
ArmaGen is developing a robust pipeline of innovative therapies for the treatment of neurological complications of lysosomal storage disorders, as well as central nervous system (CNS) diseases such as Alzheimer’s and Parkinson’s.
AvidBiotics generates non-antibody proteins that specifically target bacteria, viruses or cancer cells for human therapeutic and prophylactic uses, as well as food safety, biodefense, animal husbandry and a host of other potential applications.
AWAK Technologies is dedicated to the research, development and marketing of sorbent-based kidney dialysis machine for the treatment of patients with end-stage renal disease.
Bone Biologics is a publicly-held Biotechnology Company that is a spin off of the Musculoskeletal Transplant Foundation (MTF) using technology discovered and licensed from UCLA. Bone Biologics market and focus is in the Regenerative Medicine Orthobiologics space.
Bruin Biometrics develops innovative biometric medical device systems that can cost-effectively detect and monitor select medical conditions with urgent clinical needs.
C3 Jian is a Los Angeles-based biotechnology company focused on improving oral health through the development and commercialization of novel products based on our proprietary cell signaling platform technology
A clinical-stage biotechnology company developing novel gene therapies that have the potential to improve and protect the lives of patients by enhancing their immune systems. Calimmune’s initial disease target is HIV/AIDS.
Carbonics aims to revolutionize traditional electronics by employing earth-abundant carbon nanomaterials to vastly improve the power consumption and performance of wireless products that include next-generation smartphone and wearable devices.
CytoVale Inc. is developing a microfluidic platform to detect early signs of systemic inflammation before the onset of full-blown sepsis with the hope of enabling earlier and more successful treatment.
Enlibrium is developing novel drugs based on metformin to treat a range of different cancers by reducing cancer energy consumption and reestablishing energy balance.
Fibrocell is at the vanguard of the emerging field of personalized biologics, developing therapeutics that harness a person’s own cells to target localized treatment of rare and serious skin and connective tissue diseases.
Flex Logix Technologies, a pioneer in technology that lets chips change, today introduced EFLX, an innovative FPGA (field programmable gate array) core that allows chip makers and equipment manufacturers to update normally fixed functions in silicon at will.
GI Logic's mission is to continually innovate and evolve medical devices that help contribute to human welfare and advance the field of gastroenterology.
Holomic LLC was formed in 2011 to commercialize advanced BioPhotonics technologies invented at the world-renowned research laboratory of Professor Aydogan Ozcan at UCLA.
ImaginAb is redeﬁning therapeutic management by harnessing the power of antibody technology for in vivo imaging.
Isowalk is a company dedicated to advanced ambulation solutions for seniors, athletics, recovery, obesity and pediatrics.
Keyssa reinvented the connector. We made it simple and secure to reliably transfer huge amounts of data and video between devices with unprecedented speed.
Kite Pharma, founded in 2009, is a clinical-stage biopharmaceutical company focused on the development & commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.
KYTHERA is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market.
Librede is dedicated to reducing the complexity of biological screening. Our approach is to develop platforms, reagents and kits that enable rapid experimentation.
Lyxia® provides a pioneering technology platform to harness the prolific biofuel yield from microalgae.
MAX BioPharma is a biotech start-up leveraging small molecule lipids to create the next generation of treatments for fatal and debilitating disorders.
MediSens is working to introduce a real-time, quantiﬁable, and objective assessment medical monitoring systems to empower Healthcare industry cost containment. By collaborating closely with UCLA Wireless Health Institute, MediSens has secured, and patented key enabling technologies.
Merganser Biotech is committed to the development of new medicines for the treatment of rare hematological and iron overload diseases.
NanoH2O, Inc. develops, manufactures and markets reverse osmosis (RO) membranes that lower the cost of desalination.
Nanosys is leading the development of quantum dot technology for displays. Since our founding in 2001, we have partnered with leading display makers in creating standout tablets, TVs and smartphones that are thinner, lighter, brighter and more colorful than ever before.
Nanotech Energy, Inc., was formed in 2014 to move the world’s leading-edge research on graphene supercapacitors from the laboratory to the marketplace.
NeuroSigma, Inc. is developing and commercializing promising neuromodulation devices based on two platforms: Trigeminal Nerve Stimulation (TNS) and Deep Brain Stimulation (DBS).
ScaleFunder, Inc. serves the higher education community with a dynamic and interactive engagement platform that facilitates micro-donations to university projects.
Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders.
Sofie Biosciences is creating an ever-expanding playing field for molecular imaging through innovative PET technologies developed by great people with great ideas.
SonoSim develops and markets state-of-the-art simulation training products for physicians, nurses, students and careproviders who need to continually expand and improve their ultrasound skills.
SuperMetalix, Inc. is poised to revolutionize the market by producing cost-efficient super-hard materials and directly impact a wide range of industrial and commercial applications, from drilling and cutting tools to abrasives and scratch resistant coatings.
Tribogenics technology enables portable, compact X-ray solutions for applications in industrial testing, medical diagnosis, security screening and other industries.
Tunitas Therapeutics is a privately held biopharmaceutical company that is developing novel and precisely targeted protein therapeutics with he potential to dramatically change the lives of allergy sufferers.
Vault Nano Inc., is dedicated to providing safe and effective immunotherapy to patients suffering from cancer and infectious diseases.